Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.

Barbara Zellinger; Ulrich Bodenhofer; Immanuela A Engländer; Cornelia Kronberger; Brane Grambozov; Elvis Ruznic; Markus Stana; Josef Karner; Gerd Fastner; Karl Sotlar; Felix Sedlmayer; Franz Zehentmayr

doi:10.1007/s12282-021-01308-y

Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.

Barbara Zellinger (First author)
, Ulrich Bodenhofer
, Immanuela A Engländer
, Cornelia Kronberger (Co-author)
, Brane Grambozov (Co-author)
, Elvis Ruznic
, Markus Stana (Co-author)
, Josef Karner (Co-author)
, Gerd Fastner (Co-author)
, Karl Sotlar (Co-author)
, Felix Sedlmayer (Co-author)
, Franz Zehentmayr^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

6 Citations (Web of Science)

Original language	English
Pages (from-to)	274-286
Journal	BREAST CANCER
Volume	29
Issue number	2
DOIs	https://doi.org/10.1007/s12282-021-01308-y
Publication status	Published - 2022

Keywords

GENOME-WIDE ASSOCIATION
MICRORNA-3651 PROMOTES
DIABETIC-NEPHROPATHY
CANCER
EXPRESSION
GENE
SUSCEPTIBILITY
BIOMARKERS
DIAGNOSIS
THERAPY

Access to Document

10.1007/s12282-021-01308-y

Cite this

@article{d54277e43763410ebf6b31d97ac1dadd,

title = "Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.",

keywords = "GENOME-WIDE ASSOCIATION, MICRORNA-3651 PROMOTES, DIABETIC-NEPHROPATHY, CANCER, EXPRESSION, GENE, SUSCEPTIBILITY, BIOMARKERS, DIAGNOSIS, THERAPY",

author = "Barbara Zellinger and Ulrich Bodenhofer and Engl{\"a}nder, \{Immanuela A\} and Cornelia Kronberger and Brane Grambozov and Elvis Ruznic and Markus Stana and Josef Karner and Gerd Fastner and Karl Sotlar and Felix Sedlmayer and Franz Zehentmayr",

note = "Grambozov, Ruznic, Stana, Karner, Fastner, Sedlmayer, Zehentmayr: Engl{\"a}nder, Department of Radiation Oncology; Zellinger, Engl{\"a}nder, Sedlmayer, Zehentmayr: radART—Institute for Research and Development on Advanced Radiation Technologies; Zellinger, Kronberger, Sotlar: Department of Pathology; ALL: Paracelsus Medical University, SALK, Salzburg, Austria",

year = "2022",

doi = "10.1007/s12282-021-01308-y",

language = "English",

volume = "29",

pages = "274--286",

journal = "BREAST CANCER",

issn = "1340-6868",

number = "2",

}

TY - JOUR

T1 - Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.

AU - Zellinger, Barbara

AU - Bodenhofer, Ulrich

AU - Engländer, Immanuela A

AU - Kronberger, Cornelia

AU - Grambozov, Brane

AU - Ruznic, Elvis

AU - Stana, Markus

AU - Karner, Josef

AU - Fastner, Gerd

AU - Sotlar, Karl

AU - Sedlmayer, Felix

AU - Zehentmayr, Franz

N1 - Grambozov, Ruznic, Stana, Karner, Fastner, Sedlmayer, Zehentmayr: Engländer, Department of Radiation Oncology; Zellinger, Engländer, Sedlmayer, Zehentmayr: radART—Institute for Research and Development on Advanced Radiation Technologies; Zellinger, Kronberger, Sotlar: Department of Pathology; ALL: Paracelsus Medical University, SALK, Salzburg, Austria

PY - 2022

Y1 - 2022

KW - GENOME-WIDE ASSOCIATION

KW - MICRORNA-3651 PROMOTES

KW - DIABETIC-NEPHROPATHY

KW - CANCER

KW - EXPRESSION

KW - GENE

KW - SUSCEPTIBILITY

KW - BIOMARKERS

KW - DIAGNOSIS

KW - THERAPY

U2 - 10.1007/s12282-021-01308-y

DO - 10.1007/s12282-021-01308-y

M3 - Original Article

C2 - 34865205

SN - 1340-6868

VL - 29

SP - 274

EP - 286

JO - BREAST CANCER

JF - BREAST CANCER

IS - 2

ER -